Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05085405 · ClinicalTrials.gov registry record · NA
Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS) Trial
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT05085405: Completed NA study, sponsored by University of Michigan.
NCT05085405 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05085405, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
This is a pragmatic, single center, feasibility pilot cluster randomized trial with embedded individual randomization to evaluate implementation strategies to increase the use of evidence-based practices to reduce upper gastrointestinal bleeding risk in patients using combination antithrombotic therapy (including warfarin) and that are managed by the Michigan Medicine anticoagulation monitoring service.
Primary Outcome
The proportion of randomized patients that complete a brief medication review phone call at week 5 after up to 3 attempts.
Interventions
- BEHAVIORAL Clinician notification
- BEHAVIORAL Clinician Notification with Nurse Facilitation
- BEHAVIORAL Clinician Notification / Patient Activation
- BEHAVIORAL Clinician Notification with Nurse Facilitation / Patient Activation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-10-11 |
| Est. Completion | 2022-01-31 |
| Phase | NA |
What the finished NCT05085405 record still lists
NCT05085405 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 4 interventions - of which Clinician notification is the first listed.
NCT05085405 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05085405 about?
NCT05085405 is a clinical study titled "Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS) Trial". This is a pragmatic, single center, feasibility pilot cluster randomized trial with embedded individual randomization to evaluate implementation strategies to increase the use of evidence-based practices to reduce upper gastrointestinal bleeding risk in patients using combination antithrombotic ther...
What is the current status of trial NCT05085405?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2021-10-11. Estimated completion is 2022-01-31.
What interventions are being tested in trial NCT05085405?
The interventions under investigation include: Clinician notification (BEHAVIORAL), Clinician Notification with Nurse Facilitation (BEHAVIORAL), Clinician Notification / Patient Activation (BEHAVIORAL), Clinician Notification with Nurse Facilitation / Patient Activation (BEHAVIORAL).
Who is sponsoring clinical trial NCT05085405?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05085405's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI